Who are Salkera Emollient Foam's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): emollient cream, Colloidal Oatmeal Cream, Aqueous cream.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/salkera-emollient-foam.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Salkera Emollient Foam — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Salkera Emollient Foam (Salkera Emollient Foam) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical emollient. Area: Dermatology.

marketed Topical emollient Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

Salkera Emollient Foam (Salkera Emollient Foam) — Wright State University. Salkera Emollient Foam provides topical moisturization and skin barrier support through emollient ingredients.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Salkera Emollient Foam TARGET	Salkera Emollient Foam	Wright State University	marketed	Topical emollient
emollient cream	emollient cream	Children's Hospital Medical Center, Cincinnati	marketed	Topical emollient
Colloidal Oatmeal Cream	Colloidal Oatmeal Cream	Johnson & Johnson Consumer and Personal Products Worldwide	marketed	Topical emollient and skin protectant
Aqueous cream	Aqueous cream	The University of Hong Kong	marketed	Topical emollient

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical emollient class)

Children's Hospital Medical Center, Cincinnati · 1 drug in this class
The University of Hong Kong · 1 drug in this class
Wright State University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Salkera Emollient Foam — Competitive Intelligence Brief. https://druglandscape.com/ci/salkera-emollient-foam. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab